ADM Stock Cash Flow Statements

Archer-Daniels-Midland Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Archer-Daniels-Midland Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-06-30	2012-03-31	2011-12-31	2011-09-30

cash flows from operating activities
net earnings including non-controlling interests	217,000,000	292,000,000	561,000,000
adjustments to reconcile net earnings to net cash from operating activities
depreciation and amortization	291,000,000	287,000,000	287,000,000	288,000,000	286,000,000	280,000,000	277,000,000	261,000,000	262,000,000	259,000,000	254,000,000	260,000,000	257,000,000	257,000,000	257,000,000	247,000,000	243,000,000	249,000,000	249,000,000	238,000,000	244,000,000	245,000,000	251,000,000	249,000,000	248,000,000	245,000,000	235,000,000	232,000,000	239,000,000	235,000,000	240,000,000	232,000,000	227,000,000	225,000,000	222,000,000	226,000,000	221,000,000	231,000,000	224,000,000	217,000,000	225,000,000	216,000,000	248,000,000	214,000,000	213,000,000	219,000,000	228,000,000	227,000,000	227,000,000	227,000,000	220,000,000	214,000,000	207,000,000	207,000,000
asset impairment charges				507,000,000	7,000,000	3,000,000	189,000,000	74,000,000	43,000,000	3,000,000	17,000,000	16,000,000	3,000,000	1,000,000	71,000,000	0	23,000,000	31,000,000	4,000,000	3,000,000	3,000,000	44,000,000	92,000,000	6,000,000	35,000,000	9,000,000	109,000,000	0	21,000,000	12,000,000	20,000,000	62,000,000	18,000,000	1,000,000	6,000,000	8,000,000	9,000,000	11,000,000	61,000,000	37,000,000							236,000,000				1,000,000	16,000,000
deferred income taxes	-17,000,000	-42,000,000	-23,000,000	-15,000,000	-28,000,000	-64,000,000	-40,000,000	9,000,000	-39,000,000	47,000,000	-50,000,000	-24,000,000	-159,000,000	144,000,000	-34,000,000	-58,000,000	-30,000,000	-7,000,000	18,000,000	8,000,000	-15,000,000	64,000,000	13,000,000	-3,000,000	-28,000,000	39,000,000	77,000,000	-32,000,000	-71,000,000	-21,000,000	-687,000,000	55,000,000	-83,000,000	1,000,000	20,000,000	-50,000,000	36,000,000	50,000,000	-12,000,000	-24,000,000	25,000,000	4,000,000	-46,000,000	19,000,000	34,000,000	-66,000,000	157,000,000	69,000,000	-59,000,000	-6,000,000	-3,000,000	20,000,000	7,000,000	21,000,000
equity in earnings of affiliates, net of dividends	10,000,000	-28,000,000	-29,000,000	-30,000,000	15,000,000	-136,000,000	-79,000,000	16,000,000	33,000,000	-113,000,000	-178,000,000	-117,000,000	-3,000,000	-159,000,000	-141,000,000	-13,000,000	58,000,000	-81,000,000	-133,000,000	-72,000,000	22,000,000	-115,000,000	-121,000,000	-32,000,000	-56,000,000	-4,000,000	-100,000,000	-63,000,000	21,000,000	-105,000,000	-79,000,000	29,000,000	-20,000,000	-140,000,000	-86,000,000	55,000,000	14,000,000	-44,000,000	14,000,000	5,000,000	-2,000,000	-67,000,000	-105,000,000	17,000,000	-27,000,000	-100,000,000	-133,000,000	-26,000,000	-47,000,000	-79,000,000	-35,000,000	-102,000,000	-49,000,000	-57,000,000
stock compensation expense	22,000,000	50,000,000	0	-10,000,000	18,000,000	66,000,000	14,000,000	12,000,000	21,000,000	65,000,000	24,000,000	26,000,000	28,000,000	69,000,000	26,000,000	21,000,000	38,000,000	76,000,000	37,000,000	39,000,000	24,000,000	51,000,000	23,000,000	21,000,000	2,000,000	43,000,000	21,000,000	25,000,000	34,000,000	29,000,000	3,000,000	15,000,000	16,000,000	32,000,000	16,000,000	13,000,000	17,000,000	28,000,000	15,000,000	22,000,000	16,000,000	26,000,000	12,000,000	10,000,000	13,000,000	20,000,000	13,000,000	11,000,000	4,000,000	15,000,000	7,000,000	7,000,000	7,000,000	27,000,000
loss on sales / investment revaluation
other – net	-10,000,000	-94,000,000	89,000,000	-112,000,000	85,000,000	69,000,000	-79,000,000	-9,000,000	-10,000,000	-8,000,000	-371,000,000	237,000,000	321,000,000	-9,000,000	153,000,000	63,000,000	-57,000,000	150,000,000	-147,000,000	-198,000,000	-9,000,000	241,000,000	-296,000,000	44,000,000	112,000,000	-8,000,000	25,000,000	24,000,000	-180,000,000	64,000,000	5,000,000	54,000,000	69,000,000	51,000,000	-26,000,000	63,000,000	-32,000,000	29,000,000	-136,000,000	34,000,000	-15,000,000	-35,000,000	79,000,000	22,000,000	-12,000,000	-18,000,000	-16,000,000	-56,000,000	-1,000,000	-85,000,000	143,000,000	-64,000,000	-4,000,000	81,000,000
changes in operating assets and liabilities
segregated investments	1,041,000,000	220,000,000	-436,000,000	4,000,000	-102,000,000	-159,000,000	989,000,000	209,000,000	-457,000,000	-935,000,000	-60,000,000	301,000,000	-1,271,000,000	-482,000,000	-194,000,000	-16,000,000	-56,000,000	666,000,000	261,000,000	-423,000,000	553,000,000	17,000,000	-22,000,000	187,000,000	85,000,000	28,000,000	32,000,000	415,000,000	421,000,000	308,000,000	-8,000,000
trade receivables	852,000,000	-655,000,000	-29,000,000	656,000,000	-241,000,000	61,000,000	294,000,000	-403,000,000	358,000,000	488,000,000	-69,000,000	542,000,000	-1,218,000,000	-937,000,000	482,000,000	-350,000,000	-195,000,000	-515,000,000	194,000,000	21,000,000	-113,000,000	-251,000,000	11,000,000	147,000,000	95,000,000	34,000,000	-314,000,000	-32,000,000	155,000,000	-185,000,000	-33,000,000	-172,000,000	109,000,000	169,000,000	303,000,000	14,000,000	-305,000,000	-172,000,000	418,000,000	72,000,000	-127,000,000	550,000,000	-532,000,000	1,853,000,000	-1,329,000,000	433,000,000	204,000,000	189,000,000	49,000,000	-146,000,000	-455,000,000	2,170,000,000
inventories	2,015,000,000	137,000,000	-1,071,000,000	-210,000,000	1,148,000,000	295,000,000	-612,000,000	584,000,000	2,865,000,000	52,000,000	-885,000,000	939,000,000	2,532,000,000	-2,881,000,000	-3,244,000,000	182,000,000	1,361,000,000	-1,138,000,000	-2,796,000,000	-1,069,000,000	1,257,000,000	182,000,000	-1,015,000,000	142,000,000	686,000,000	166,000,000	-352,000,000	-578,000,000	1,756,000,000	-600,000,000	-840,000,000	-426,000,000	907,000,000	222,000,000	-1,707,000,000	770,000,000	-123,000,000	406,000,000	-815,000,000	353,000,000	595,000,000	739,000,000	-1,907,000,000	780,000,000	2,373,000,000	28,000,000	-2,247,000,000	1,161,000,000	2,241,000,000	1,386,000,000	837,000,000	-629,000,000	-1,289,000,000	809,000,000
other current assets	-304,000,000	263,000,000	-80,000,000	117,000,000	465,000,000	163,000,000	568,000,000	-456,000,000	254,000,000	328,000,000	650,000,000	664,000,000	548,000,000	-2,141,000,000	111,000,000	407,000,000	367,000,000	413,000,000	-1,659,000,000	591,000,000	-622,000,000	-436,000,000	-1,005,000,000	23,000,000	28,000,000	-495,000,000	650,000,000	-201,000,000	-87,000,000	-432,000,000	-641,000,000	-96,000,000	1,026,000,000	387,000,000	239,000,000	-400,000,000	-143,000,000	128,000,000	613,000,000	-888,000,000	919,000,000	-184,000,000	702,000,000	-1,838,000,000	1,167,000,000	189,000,000	-388,000,000	-381,000,000	915,000,000	81,000,000	-558,000,000	-1,354,000,000
trade payables	-734,000,000	-423,000,000	699,000,000	-161,000,000	-544,000,000	-713,000,000	1,017,000,000	201,000,000	-1,206,000,000	-1,556,000,000	1,084,000,000	1,015,000,000	-465,000,000	-245,000,000	1,749,000,000	1,193,000,000	-582,000,000	-441,000,000	1,083,000,000	430,000,000	-559,000,000	-260,000,000	744,000,000	-66,000,000	-482,000,000	-260,000,000	476,000,000	489,000,000	-698,000,000	-567,000,000	440,000,000	498,000,000	-548,000,000	-209,000,000	715,000,000	156,000,000	-183,000,000	-527,000,000	424,000,000	28,000,000	-155,000,000	-1,071,000,000	1,213,000,000	295,000,000	-751,000,000	-851,000,000	1,863,000,000	-95,000,000	-507,000,000	-1,552,000,000	-591,000,000	-1,071,000,000
payables to brokerage customers	787,000,000	-79,000,000	171,000,000	141,000,000	-709,000,000	319,000,000	-479,000,000	-367,000,000	-753,000,000	-460,000,000	-815,000,000	-814,000,000	19,000,000	2,501,000,000	291,000,000	887,000,000	788,000,000	561,000,000	340,000,000	179,000,000	70,000,000	811,000,000	84,000,000	192,000,000	98,000,000	-27,000,000	124,000,000	231,000,000	-232,000,000	-432,000,000	-167,000,000	1,000,000	-398,000,000	303,000,000	-268,000,000	-145,000,000	283,000,000	217,000,000	60,000,000	498,000,000	-607,000,000	73,000,000	207,000,000	484,000,000	239,000,000	237,000,000
accrued expenses and other payables	-153,000,000	-244,000,000	127,000,000	104,000,000	-359,000,000	-148,000,000	-131,000,000	-90,000,000	268,000,000	-837,000,000	-128,000,000	-63,000,000	-1,216,000,000	1,363,000,000	696,000,000	-345,000,000	26,000,000	-450,000,000	873,000,000	654,000,000	-728,000,000	488,000,000	771,000,000	-134,000,000	97,000,000	-169,000,000	-61,000,000	-287,000,000	152,000,000	231,000,000	1,010,000,000	55,000,000	-1,000,000,000	-541,000,000	182,000,000	293,000,000	-111,000,000	-469,000,000	-62,000,000	784,000,000	-895,000,000	-770,000,000	240,000,000	1,378,000,000	-1,040,000,000	-375,000,000	-191,000,000	1,129,000,000	-1,156,000,000	469,000,000	505,000,000	-334,000,000
net cash from operating activities	4,298,000,000	-342,000,000	322,000,000
cash flows from investing activities
capital expenditures	-305,000,000	-291,000,000	-492,000,000	-381,000,000	-362,000,000	-328,000,000	-439,000,000	-441,000,000	-287,000,000	-327,000,000	-478,000,000
free cash flows	3,993,000,000	-633,000,000	-170,000,000
net assets of businesses acquired	-5,000,000	-90,000,000	9,000,000	0	-21,000,000	-915,000,000	-12,000,000								-1,063,000,000	-496,000,000			-12,000,000	0	5,000,000	-8,000,000	0	-2,000,000	-68,000,000	-1,876,000,000	-140,000,000				0	-7,000,000	-90,000,000	-90,000,000	6,000,000	-16,000,000	-36,000,000	-84,000,000	-396,000,000	-14,000,000			-2,755,000,000				-9,000,000	-19,000,000	0	-16,000,000	-2,000,000	-33,000,000	-194,000,000	-12,000,000
proceeds from sales of assets	31,000,000	10,000,000		15,000,000	10,000,000	6,000,000
purchases of marketable securities	0	-11,000,000																	0	1,000,000			-1,000,000	-24,000,000							-39,000,000	-181,000,000	-170,000,000	-148,000,000	-274,000,000	-325,000,000	-376,000,000	-426,000,000	-263,000,000	-276,000,000	-299,000,000	-246,000,000	-459,000,000	-244,000,000	-279,000,000	-362,000,000	-361,000,000	-187,000,000	-228,000,000	-115,000,000	-167,000,000	-241,000,000	-708,000,000	-181,000,000
proceeds from sales of marketable securities	19,000,000	248,000,000																1,000,000	5,000,000			5,000,000	37,000,000	0	17,000,000	50,000,000					413,000,000	148,000,000	204,000,000	220,000,000	497,000,000	297,000,000	489,000,000	376,000,000	176,000,000	208,000,000	389,000,000	346,000,000	288,000,000	260,000,000	370,000,000	321,000,000	169,000,000	159,000,000	161,000,000	506,000,000	419,000,000	442,000,000	603,000,000	481,000,000
net cash from investing activities	-262,000,000	-129,000,000
cash flows from financing activities
net (repayments) borrowings under lines of credit agreements
share repurchases, net of tax
cash dividends	-248,000,000	-247,000,000	-241,000,000	-241,000,000	-246,000,000	-257,000,000	-239,000,000	-244,000,000	-246,000,000	-248,000,000	-222,000,000	-224,000,000	-227,000,000	-226,000,000	-208,000,000	-209,000,000	-209,000,000	-208,000,000	-202,000,000	-202,000,000	-202,000,000	-203,000,000	-197,000,000	-197,000,000	-197,000,000	-198,000,000	-190,000,000	-189,000,000	-189,000,000	-190,000,000	-186,000,000	-180,000,000	-181,000,000	-183,000,000	-173,000,000	-175,000,000	-176,000,000	-177,000,000	-167,000,000	-170,000,000	-173,000,000	-177,000,000	-154,000,000	-155,000,000	-157,000,000	-158,000,000	-125,000,000	-126,000,000	-125,000,000	-125,000,000	-116,000,000	-115,000,000	-117,000,000	-107,000,000
acquisition of non-controlling interest
net cash from financing activities	-2,166,000,000	587,000,000
effect of exchange rate on cash, cash equivalents, restricted cash, and restricted cash equivalents	18,000,000	16,000,000	-30,000,000	20,000,000	-1,000,000	-13,000,000	19,000,000	-19,000,000	3,000,000	-6,000,000
increase in cash, cash equivalents, restricted cash, and restricted cash equivalents	1,888,000,000	132,000,000			-574,000,000	-545,000,000	349,000,000	-146,000,000	-500,000,000	-1,346,000,000	-457,000,000	-133,000,000	-1,601,000,000	1,770,000,000	-204,000,000	975,000,000	831,000,000	1,206,000,000	387,000,000	-240,000,000	-3,031,000,000	4,540,000,000	-35,000,000	276,000,000	147,000,000	-1,241,000,000	1,194,000,000	598,000,000	310,000,000	-117,000,000	64,000,000	424,000,000	-39,000,000	-152,000,000
cash, cash equivalents, restricted cash, and restricted cash equivalents - beginning of period	0	3,924,000,000		0	0	5,390,000,000		0	0	7,033,000,000		0	0	7,454,000,000		0	0	4,646,000,000		0	0	2,990,000,000		0	0	3,843,000,000		0	0	1,858,000,000		873,000,000	0	688,000,000
cash, cash equivalents, restricted cash, and restricted cash equivalents - end of period	1,888,000,000	4,056,000,000		126,000,000	-574,000,000	4,845,000,000		-146,000,000	-500,000,000	5,687,000,000		-133,000,000	-1,601,000,000	9,224,000,000		975,000,000	831,000,000	5,852,000,000		-240,000,000	-3,031,000,000	7,530,000,000		276,000,000	147,000,000	2,602,000,000		598,000,000	310,000,000	1,741,000,000		1,297,000,000	-39,000,000	536,000,000
balance march 31, 2025
comprehensive income
net earnings
other comprehensive income
cash dividends paid - 0.51 per share
share repurchases					-1,000,000,000	-1,327,000,000	-1,555,000,000	-117,000,000	-650,000,000	-351,000,000	-250,000,000	-1,000,000,000							-16,000,000	-5,000,000	0	-112,000,000	0	-56,000,000							-74,000,000	-165,000,000	-263,000,000	-248,000,000
stock option exercises, net of taxes
other
balance june 30, 2025
balance, december 31, 2024
cash dividends paid - 1.02 per share
balance, june 30, 2025
balance march 31, 2024
other comprehensive loss
cash dividends paid - 0.50 per share
balance june 30, 2024
balance, balance december 31, 2023
cash dividends paid - 1.00 per share
(gain) loss on sales / investment revaluation		-26,000,000
net borrowings under lines of credit agreements		863,000,000
impairment of goodwill, intangibles, long-lived assets, and investments
deferred cash flow hedges			75,000,000	3,000,000	-49,000,000	-69,000,000	28,000,000	128,000,000	-37,000,000	-104,000,000	-329,000,000	39,000,000	-77,000,000	283,000,000	-224,000,000	75,000,000	81,000,000	102,000,000	143,000,000	112,000,000	81,000,000	-82,000,000		-2,000,000	14,000,000	-77,000,000		79,000,000	-65,000,000	-25,000,000		-27,000,000	36,000,000	3,000,000		-54,000,000	34,000,000	10,000,000		-46,000,000	38,000,000	-56,000,000		59,000,000	70,000,000	-97,000,000		15,000,000	-9,000,000	12,000,000	76,000,000	-43,000,000	1,000,000	9,000,000
(gain) loss on sales of assets and businesses/investment revaluation
changes in operating assets and liabilities, net of acquisitions and dispositions
proceeds from sales of assets, businesses and investments
investments in affiliates			-14,000,000	-36,000,000	-4,000,000	-4,000,000	-10,000,000	-2,000,000	-2,000,000	-4,000,000	-17,000,000
cost method investments								0
long-term debt borrowings							1,000,000	0			0	1,000,000	1,000,000	750,000,000	-1,000,000	735,000,000	2,000,000	593,000,000	1,000,000	312,000,000	-3,000,000	1,481,000,000	5,000,000	1,000,000			1,000,000,000				23,000,000	492,000,000			5,000,000				6,000,000	2,000,000	1,236,000,000	8,000,000	0	0	0	1,000,000	0	3,000,000	3,000,000	17,000,000	2,000,000	4,000,000	89,000,000	2,000,000
long-term debt payments							0	-301,000,000	-660,000,000	-2,000,000	0				-1,000,000	-531,000,000			-104,000,000	-1,507,000,000	-524,000,000	-1,000,000	-11,000,000	-4,000,000	-607,000,000	-4,000,000	-17,000,000	-7,000,000	-5,000,000	-1,000,000	5,000,000	-571,000,000	-267,000,000	-2,000,000	-5,000,000	-1,000,000	-4,000,000	-4,000,000	-29,000,000	-937,000,000	-21,000,000	-7,000,000	-84,000,000	-5,000,000	-8,000,000	-1,154,000,000	-10,000,000	-5,000,000	-10,000,000	-250,000,000	-134,000,000	-51,000,000	-88,000,000	-85,000,000
net change in short-term debt
acquisition of non-controlling interests
net increase in cash, cash equivalents, restricted cash, and restricted cash equivalents
cash, cash equivalents, restricted cash, and restricted cash equivalents – beginning of year
cash, cash equivalents, restricted cash, and restricted cash equivalents – end of year
reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents to the consolidated balance sheets
cash and cash equivalents			-173,000,000	20,000,000	-66,000,000	830,000,000	-130,000,000	72,000,000	527,000,000	899,000,000	-62,000,000	193,000,000	-173,000,000	1,079,000,000	-140,000,000	214,000,000	175,000,000	694,000,000	-282,000,000	-255,000,000	-3,531,000,000	4,734,000,000	-80,000,000	83,000,000	-77,000,000	926,000,000	1,082,000,000	64,000,000	54,000,000	797,000,000	286,000,000	85,000,000	-43,000,000	476,000,000
restricted cash and restricted cash equivalents included in segregated cash and investments			-300,000,000	106,000,000	-508,000,000	4,015,000,000	479,000,000	-218,000,000	-1,027,000,000	4,788,000,000	-395,000,000	-326,000,000	-1,428,000,000	8,145,000,000	-64,000,000	761,000,000	656,000,000	5,158,000,000	669,000,000	15,000,000	500,000,000	2,796,000,000	45,000,000	193,000,000	224,000,000	1,676,000,000	112,000,000	534,000,000	256,000,000	944,000,000	-222,000,000	1,212,000,000	4,000,000	60,000,000
total cash, cash equivalents, restricted cash, and restricted cash equivalents			-473,000,000	126,000,000	-574,000,000	4,845,000,000	349,000,000	-146,000,000	-500,000,000	5,687,000,000	-457,000,000	-133,000,000	-1,601,000,000	9,224,000,000	-204,000,000	975,000,000	831,000,000	5,852,000,000	387,000,000	-240,000,000	-3,031,000,000	7,530,000,000	-35,000,000	276,000,000	147,000,000	2,602,000,000	1,194,000,000	598,000,000	310,000,000	1,741,000,000	64,000,000	1,297,000,000	-39,000,000	536,000,000
cash paid for interest and income taxes were as follows:
interest
income taxes
balance, december 31, 2021
other comprehensive (loss), net of tax
cash dividends paid-1.60 per share
balance, december 31, 2022
other comprehensive income, net of tax
cash dividends paid-1.80 per share
balance, december 31, 2023
cash dividends paid-2.00 per share
operating activities
gain on sales/revaluation of assets
investing activities
net cash used by investing activities
financing activities
net borrowings (payments) under lines of credit agreements				-581,000,000	589,000,000	1,619,000,000	-11,000,000	-8,000,000	-1,677,000,000	1,306,000,000	323,000,000				641,000,000	-974,000,000	-1,481,000,000	729,000,000	1,830,000,000	-326,000,000	-2,855,000,000	2,188,000,000	-41,000,000	-453,000,000	104,000,000	1,309,000,000	-426,000,000	-513,000,000	-1,278,000,000	1,474,000,000	127,000,000	363,000,000	-68,000,000	263,000,000	-46,000,000	-1,347,000,000	757,000,000	697,000,000	-852,000,000	784,000,000	-692,000,000	742,000,000	-280,000,000	-49,000,000	-66,000,000	-63,000,000	28,000,000	-702,000,000	-1,346,000,000	-441,000,000		1,112,000,000	-413,000,000	-663,000,000
net cash used by financing activities
decrease in cash, cash equivalents, restricted cash, and restricted cash equivalents
net earnings including noncontrolling interests					481,000,000	719,000,000	542,000,000	824,000,000	928,000,000	1,172,000,000	1,024,000,000	1,037,000,000	1,240,000,000	1,064,000,000	797,000,000	533,000,000	712,000,000	693,000,000	693,000,000	226,000,000	472,000,000	391,000,000	499,000,000	408,000,000	238,000,000	234,000,000	317,000,000	536,000,000	566,000,000	396,000,000	792,000,000	195,000,000	275,000,000	340,000,000	426,000,000	344,000,000	288,000,000	230,000,000	717,000,000	253,000,000	383,000,000	493,000,000	705,000,000	748,000,000	532,000,000	268,000,000	377,000,000	481,000,000	226,000,000	270,000,000	293,000,000	405,000,000	83,000,000	461,000,000
(gain) losses on sales/revaluation of assets					-5,000,000	14,000,000
total operating activities					468,000,000	700,000,000	2,569,000,000	992,000,000	2,509,000,000	-1,610,000,000	130,000,000	4,023,000,000	531,000,000	-1,206,000,000	742,000,000	2,846,000,000	2,709,000,000	298,000,000	-870,000,000	-1,080,000,000	219,000,000	-655,000,000	-1,813,000,000	-926,000,000	-678,000,000	-2,035,000,000	-1,104,000,000	-501,000,000	395,000,000	-3,574,000,000	56,000,000	841,000,000	905,000,000	409,000,000	319,000,000	1,522,000,000	-389,000,000	23,000,000	1,383,000,000	691,000,000	362,000,000	45,000,000	538,000,000	3,441,000,000	1,341,000,000	-358,000,000	357,000,000	2,521,000,000	1,991,000,000	357,000,000	637,000,000	-783,000,000	954,000,000	2,087,000,000
distributions from affiliates																0	0	5,000,000																		0	4,000,000	7,000,000		1,000,000	0	1,000,000		7,000,000	3,000,000	78,000,000		14,000,000
total investing activities					-382,000,000	-1,230,000,000	-435,000,000	-450,000,000	-283,000,000	-328,000,000	-452,000,000	-301,000,000	-305,000,000	-342,000,000	-1,382,000,000	-893,000,000	-225,000,000	-169,000,000	-263,000,000	2,555,000,000	320,000,000	1,853,000,000	2,008,000,000	1,905,000,000	1,617,000,000	-271,000,000	2,007,000,000	1,027,000,000	1,368,000,000	2,180,000,000	47,000,000	-367,000,000	-185,000,000	-381,000,000	20,000,000	-418,000,000	-365,000,000	-448,000,000	286,000,000	100,000,000	-146,000,000	-261,000,000	-2,987,000,000	-163,000,000	-112,000,000	-145,000,000	-403,000,000	-232,000,000	-111,000,000	169,000,000	-25,000,000	-163,000,000	-685,000,000	-249,000,000
total financing activities					-659,000,000	-2,000,000	-1,804,000,000	-669,000,000	-2,729,000,000	598,000,000	-135,000,000	-3,855,000,000	-1,827,000,000	3,318,000,000	436,000,000	-978,000,000	-1,653,000,000	1,077,000,000	1,520,000,000	-1,715,000,000	-3,570,000,000	3,342,000,000	-230,000,000	-703,000,000	-792,000,000	1,065,000,000	291,000,000	72,000,000	-1,453,000,000	1,277,000,000	-39,000,000	-50,000,000	-759,000,000	-180,000,000	-445,000,000	-737,000,000	382,000,000	221,000,000	-1,479,000,000	-938,000,000	-239,000,000	7,000,000	-991,000,000	-369,000,000	-682,000,000	-1,535,000,000	-85,000,000	-885,000,000	-1,480,000,000	-792,000,000	-139,000,000	900,000,000	-725,000,000	-1,133,000,000
adjustments to reconcile net earnings to net cash from operating results
loss on debt extinguishment															0				-1,000,000	396,000,000
proceeds from sales of assets and businesses							39,000,000	4,000,000	4,000,000	13,000,000	80,000,000	39,000,000	7,000,000	5,000,000	172,000,000	15,000,000	44,000,000	14,000,000	20,000,000
gains on sales of assets and businesses/investment revaluation								-1,000,000	-21,000,000	-11,000,000		-35,000,000	-8,000,000	-34,000,000		-16,000,000
deferred consideration in securitized receivables																			0	-2,147,000,000	-411,000,000	-2,045,000,000	-1,967,000,000	-2,101,000,000	-1,835,000,000	-1,778,000,000	-2,425,000,000	-1,306,000,000	-1,657,000,000	-2,450,000,000
investments in retained interest in securitized receivables																			0	0	-850,000,000	-1,271,000,000	-1,585,000,000	-1,223,000,000	-1,277,000,000	-1,313,000,000	-3,566,000,000	-1,207,000,000	-886,000,000	-1,298,000,000
proceeds from retained interest in securitized receivables																			0	2,147,000,000	1,261,000,000	3,316,000,000	3,552,000,000	3,324,000,000	3,112,000,000	3,091,000,000	5,991,000,000	2,592,000,000	2,556,000,000	3,656,000,000
supplemental disclosure of noncash investing activity:
retained interest in securitized receivables																			0	1,273,000,000	1,278,000,000	2,105,000,000	2,094,000,000	1,995,000,000	1,831,000,000	1,831,000,000	2,299,000,000	1,620,000,000	1,610,000,000	2,368,000,000
purchases of property, plant, and equipment													-283,000,000	-217,000,000		-287,000,000	-253,000,000	-174,000,000	-265,000,000	-198,000,000	-166,000,000	-194,000,000	-262,000,000	-183,000,000	-185,000,000	-198,000,000	-287,000,000	-176,000,000	-183,000,000	-196,000,000	-353,000,000	-244,000,000	-252,000,000	-200,000,000	-261,000,000	-225,000,000	-216,000,000	-180,000,000	-306,000,000	-279,000,000	-296,000,000	-244,000,000	-289,000,000	-207,000,000	-210,000,000	-188,000,000	-254,000,000	-217,000,000	-194,000,000	-248,000,000	-284,000,000	-341,000,000	-409,000,000	-443,000,000
investments in and advances to affiliates													-22,000,000	-36,000,000	-27,000,000	1,000,000	-4,000,000	-4,000,000	0	0	-2,000,000	-3,000,000	-1,000,000	-2,000,000	-1,000,000	-9,000,000	-30,000,000	5,000,000			1,000,000	-95,000,000	-1,000,000	-185,000,000	-34,000,000	-164,000,000				-1,000,000
net borrowings (payments) under short-term credit agreements													-1,410,000,000	2,824,000,000
gains on sales of assets and businesses																		-11,000,000		-68,000,000				-7,000,000	-15,000,000	-15,000,000		-33,000,000
(gain) loss on sales of assets and businesses
proceeds from sales of business and assets																					84,000,000	7,000,000		20,000,000	5,000,000	18,000,000		151,000,000	12,000,000	14,000,000		23,000,000	124,000,000	25,000,000		8,000,000
pension and postretirement accruals (contributions)																														-26,000,000				11,000,000	-76,000,000	-86,000,000	12,000,000	15,000,000	42,000,000	-170,000,000	20,000,000	-4,000,000	7,000,000	3,000,000	1,000,000	2,000,000	3,000,000	-5,000,000
gain on sale or revaluation of assets
proceeds from sale of business and assets
gain on sale and revaluation of assets
debt repurchase premium and costs
gains on sales of assets and businesses/revaluation																														-6,000,000		-15,000,000
segregated cash and investments																																	317,000,000	-430,000,000	356,000,000	311,000,000	-288,000,000	-117,000,000	0	-449,000,000	15,000,000	131,000,000	-140,000,000	-406,000,000	-142,000,000	-247,000,000	38,000,000	-221,000,000	104,000,000	-243,000,000	273,000,000	-84,000,000	-74,000,000	13,000,000
gains on sales of assets/revaluations																																		-16,000,000		4,000,000
adjustments to reconcile net earnings to net cash
provided by operating activities
cash divested from deconsolidation																																																			0	0	0	-130,000,000
purchases of treasury stock																																			-246,000,000	-267,000,000	-191,000,000	-296,000,000	-252,000,000	-624,000,000	-598,000,000	-566,000,000	-481,000,000	-209,000,000	-318,000,000	-175,000,000	-6,000,000	-84,000,000			-44,000,000	-56,000,000	-187,000,000	-240,000,000
acquisition of noncontrolling interest																																												0								0	-10,000,000	-9,000,000
increase in cash and cash equivalents																																				367,000,000	-372,000,000	-204,000,000	190,000,000	-147,000,000	-23,000,000	-209,000,000	-3,440,000,000	2,909,000,000			-131,000,000	1,404,000,000	400,000,000	-266,000,000	473,000,000	-46,000,000	-456,000,000	705,000,000
cash and cash equivalents beginning of period																																				0	0	910,000,000		0	0	1,099,000,000		0	0	3,121,000,000		0	0	1,714,000,000		0	0	615,000,000
cash and cash equivalents end of period																																				367,000,000	-372,000,000	706,000,000		-147,000,000	-23,000,000	890,000,000		2,909,000,000	547,000,000	1,083,000,000		1,404,000,000	400,000,000	1,448,000,000		-46,000,000	-456,000,000	1,320,000,000
gain on sale of assets																																						-3,000,000
proceeds from sales of property, plant, and equipment																																						11,000,000				6,000,000		10,000,000	13,000,000	6,000,000		10,000,000	16,000,000	10,000,000	9,000,000	15,000,000	21,000,000	3,000,000
acquisition of noncontrolling interests
cash and cash equivalents – beginning of year
cash and cash equivalents – end of year
gains on sales of assets and revaluation																																								-35,000,000
proceeds from sales of assets and business																																								459,000,000
gain on sale of assets and equity dilution
gains on sales of assets and equity dilution
changes in operating assets and liabilities, net of businesses acquired
decrease in cash and cash equivalents																																														-2,038,000,000
proceeds from sale of assets
shares issued related to equity unit conversion
debt exchange premiums																																																				0	0	-32,000,000
adjustments to reconcile net earnings to net cash provided by
(used in) operating activities
pension and postretirement accruals																																																		8,000,000		66,000,000	26,000,000	33,000,000
asset impairment charge
cash and cash equivalents – beginning of period
cash and cash equivalents – end of period
gain on golden peanut revaluation
charges from early extinguishment of debt
receivables																																																						-874,000,000
other assets																																																						233,000,000
accounts payable and accrued expenses																																																						1,124,000,000
equity in (earnings) losses of affiliates, net of dividends
charges on early extinguishment of debt
proceeds from sale of businesses
net borrowings (payments) under line of credit agreements

We provide you with 20 years of cash flow statements for Archer-Daniels-Midland stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Archer-Daniels-Midland stock. Explore the full financial landscape of Archer-Daniels-Midland stock with our expertly curated income statements.

The information provided in this report about Archer-Daniels-Midland stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.